Assessing the efficacy and safety of angiotensinogen inhibition using human genetics
View ORCID ProfileJonas Bovijn, View ORCID ProfileJenny C Censin, View ORCID ProfileCecilia M Lindgren, View ORCID ProfileMichael V Holmes
doi: https://doi.org/10.1101/2020.08.13.20174094
Jonas Bovijn
1Big Data Institute at the Li Ka Shing Centre for Health Information and Discovery, University of Oxford, Oxford, OX3 7FZ, United Kingdom
2Wellcome Centre for Human Genetics, University of Oxford, Oxford, OX3 7BN, United Kingdom
MDJenny C Censin
1Big Data Institute at the Li Ka Shing Centre for Health Information and Discovery, University of Oxford, Oxford, OX3 7FZ, United Kingdom
2Wellcome Centre for Human Genetics, University of Oxford, Oxford, OX3 7BN, United Kingdom
MDCecilia M Lindgren
1Big Data Institute at the Li Ka Shing Centre for Health Information and Discovery, University of Oxford, Oxford, OX3 7FZ, United Kingdom
2Wellcome Centre for Human Genetics, University of Oxford, Oxford, OX3 7BN, United Kingdom
3Program in Medical and Population Genetics, Broad Institute, Cambridge, MA, 02142, USA
4National Institute for Health Research Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Oxford, OX3 9DU, United Kingdom
PhDMichael V Holmes
1Big Data Institute at the Li Ka Shing Centre for Health Information and Discovery, University of Oxford, Oxford, OX3 7FZ, United Kingdom
4National Institute for Health Research Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Oxford, OX3 9DU, United Kingdom
5Clinical Trial Service Unit and Epidemiological Studies Unit (CTSU), Nuffield Department of Population Health, University of Oxford, Oxford, OX3 7LF, United Kingdom
6Medical Research Council Population Health Research Unit (MRC PHRU), Nuffield Department of Population Health, University of Oxford, Oxford, OX3 7LF, United Kingdom
MD, PhD
Posted August 14, 2020.
Assessing the efficacy and safety of angiotensinogen inhibition using human genetics
Jonas Bovijn, Jenny C Censin, Cecilia M Lindgren, Michael V Holmes
medRxiv 2020.08.13.20174094; doi: https://doi.org/10.1101/2020.08.13.20174094
Subject Area
Subject Areas
- Addiction Medicine (357)
- Allergy and Immunology (681)
- Anesthesia (182)
- Cardiovascular Medicine (2697)
- Dermatology (231)
- Emergency Medicine (406)
- Epidemiology (12336)
- Forensic Medicine (10)
- Gastroenterology (773)
- Genetic and Genomic Medicine (4181)
- Geriatric Medicine (393)
- Health Economics (690)
- Health Informatics (2704)
- Health Policy (1011)
- Hematology (366)
- HIV/AIDS (865)
- Medical Education (401)
- Medical Ethics (110)
- Nephrology (446)
- Neurology (3962)
- Nursing (216)
- Nutrition (587)
- Oncology (2090)
- Ophthalmology (597)
- Orthopedics (245)
- Otolaryngology (309)
- Pain Medicine (254)
- Palliative Medicine (76)
- Pathology (474)
- Pediatrics (1136)
- Primary Care Research (464)
- Public and Global Health (6596)
- Radiology and Imaging (1431)
- Respiratory Medicine (879)
- Rheumatology (416)
- Sports Medicine (347)
- Surgery (458)
- Toxicology (56)
- Transplantation (192)
- Urology (170)